Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Adrian Fretland, Ph.D.
Executive Director of Clinical Pharmacology and Toxicology
Repare Therapeutics
Poster(s):
184: Population Pharmacokinetic Modelling of RP-6306, a Novel PKMYT1 Inhibitor, in Cancer Patients from a Phase 1 Dose Escalation Study
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT